Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Ancillary investigations to diagnose parkinsonism: a prospective clinical study.

Aerts MB, Esselink RA, Abdo WF, Meijer FJ, Drost G, Norgren N, Janssen MJ, Borm GF, Bloem BR, Verbeek MM.

J Neurol. 2014 Nov 9. [Epub ahead of print]

PMID:
25381460
[PubMed - as supplied by publisher]
2.

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.

IntHout J, Ioannidis JP, Borm GF.

BMC Med Res Methodol. 2014 Feb 18;14:25. doi: 10.1186/1471-2288-14-25.

PMID:
24548571
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28.

PMID:
24166522
[PubMed - indexed for MEDLINE]
4.

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Borm GF, Tjan-Heijnen VC.

Breast Cancer Res Treat. 2013 Oct;141(3):507-14. doi: 10.1007/s10549-013-2711-y. Epub 2013 Oct 9.

PMID:
24104881
[PubMed - indexed for MEDLINE]
5.

Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).

van der Marck MA, Munneke M, Mulleners W, Hoogerwaard EM, Borm GF, Overeem S, Bloem BR; IMPACT study group.

Lancet Neurol. 2013 Oct;12(10):947-56. doi: 10.1016/S1474-4422(13)70196-0. Epub 2013 Aug 27.

PMID:
23988337
[PubMed - indexed for MEDLINE]
6.

Impact of falls and fear of falling on health-related quality of life in patients with Parkinson's disease.

Grimbergen YA, Schrag A, Mazibrada G, Borm GF, Bloem BR.

J Parkinsons Dis. 2013 Jan 1;3(3):409-13. doi: 10.3233/JPD-120113.

PMID:
23948987
[PubMed - indexed for MEDLINE]
7.

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

Vriens BE, Aarts MJ, de Vries B, van Gastel SM, Wals J, Smilde TJ, van Warmerdam LJ, de Boer M, van Spronsen DJ, Borm GF, Tjan-Heijnen VC; Breast Cancer Trialists' Group of the Netherlands (BOOG).

Eur J Cancer. 2013 Oct;49(15):3102-10. doi: 10.1016/j.ejca.2013.06.012. Epub 2013 Jul 10.

PMID:
23850450
[PubMed - indexed for MEDLINE]
8.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29.

PMID:
23630211
[PubMed - indexed for MEDLINE]
9.

Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans.

van den Munckhof I, Riksen N, Seeger JP, Schreuder TH, Borm GF, Eijsvogels TM, Hopman MT, Rongen GA, Thijssen DH.

Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1727-32. doi: 10.1152/ajpheart.00054.2013. Epub 2013 Apr 19.

PMID:
23604707
[PubMed - indexed for MEDLINE]
Free Article
10.

Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial.

van Nimwegen M, Speelman AD, Overeem S, van de Warrenburg BP, Smulders K, Dontje ML, Borm GF, Backx FJ, Bloem BR, Munneke M; ParkFit Study Group.

BMJ. 2013 Mar 1;346:f576. doi: 10.1136/bmj.f576.

PMID:
23457213
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial.

Sturkenboom IH, Graff MJ, Borm GF, Adang EM, Nijhuis-van der Sanden MW, Bloem BR, Munneke M.

Trials. 2013 Feb 2;14:34. doi: 10.1186/1745-6215-14-34.

PMID:
23374761
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.

van der Marck MA, Bloem BR, Borm GF, Overeem S, Munneke M, Guttman M.

Mov Disord. 2013 May;28(5):605-11. doi: 10.1002/mds.25194. Epub 2012 Nov 19.

PMID:
23165981
[PubMed - indexed for MEDLINE]
13.

Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables.

Jacobs B, Beems T, van der Vliet TM, van Vugt AB, Hoedemaekers C, Horn J, Franschman G, Haitsma I, van der Naalt J, Andriessen TM, Borm GF, Vos PE.

Neurocrit Care. 2013 Aug;19(1):79-89. doi: 10.1007/s12028-012-9795-9.

PMID:
23138545
[PubMed - indexed for MEDLINE]
14.

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.

Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R, Larsen JP.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):537-43. doi: 10.1136/jnnp-2012-303808. Epub 2012 Oct 31.

PMID:
23117496
[PubMed - indexed for MEDLINE]
15.

Obtaining evidence by a single well-powered trial or several modestly powered trials.

Inthout J, Ioannidis JP, Borm GF.

Stat Methods Med Res. 2012 Oct 14. [Epub ahead of print]

PMID:
23070590
[PubMed - as supplied by publisher]
16.

Meier-Gorlin syndrome: growth and secondary sexual development of a microcephalic primordial dwarfism disorder.

de Munnik SA, Otten BJ, Schoots J, Bicknell LS, Aftimos S, Al-Aama JY, van Bever Y, Bober MB, Borm GF, Clayton-Smith J, Deal CL, Edrees AY, Feingold M, Fryer A, van Hagen JM, Hennekam RC, Jansweijer MC, Johnson D, Kant SG, Opitz JM, Ramadevi AR, Reardon W, Ross A, Sarda P, Schrander-Stumpel CT, Sluiter AE, Temple IK, Terhal PA, Toutain A, Wise CA, Wright M, Skidmore DL, Samuels ME, Hoefsloot LH, Knoers NV, Brunner HG, Jackson AP, Bongers EM.

Am J Med Genet A. 2012 Nov;158A(11):2733-42. doi: 10.1002/ajmg.a.35681. Epub 2012 Sep 28.

PMID:
23023959
[PubMed - indexed for MEDLINE]
17.

Development and external validation of a new PTA assessment scale.

Jacobs B, van Ekert J, Vernooy LP, Dieperink P, Andriessen TM, Hendriks MP, van Vugt AB, Emons MA, Borm GF, Vos PE.

BMC Neurol. 2012 Aug 8;12:69.

PMID:
22873279
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Health status one year after TransInguinal PrePeritoneal inguinal hernia repair and Lichtenstein's method: an analysis alongside a randomized clinical study.

Koning GG, de Vries J, Borm GF, Koeslag L, Vriens PW, van Laarhoven CJ.

Hernia. 2013 Jun;17(3):299-306. doi: 10.1007/s10029-012-0963-9. Epub 2012 Aug 8.

PMID:
22872429
[PubMed - indexed for MEDLINE]
19.

The impact of occupational therapy in Parkinson's disease: a randomized controlled feasibility study.

Sturkenboom IH, Graff MJ, Borm GF, Veenhuizen Y, Bloem BR, Munneke M, Nijhuis-van der Sanden MW.

Clin Rehabil. 2013 Feb;27(2):99-112. doi: 10.1177/0269215512448382. Epub 2012 Jul 18.

PMID:
22811447
[PubMed - indexed for MEDLINE]
20.

First trial reactions and habituation rates over successive balance perturbations in Parkinson's disease.

Nanhoe-Mahabier W, Allum JH, Overeem S, Borm GF, Oude Nijhuis LB, Bloem BR.

Neuroscience. 2012 Aug 16;217:123-9. doi: 10.1016/j.neuroscience.2012.03.064. Epub 2012 Apr 24.

PMID:
22542872
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk